In the last 12 months, insiders at Ventyx Biosciences, Inc. ($VTYX) filed 138 transactions with the SEC: 3 open-market purchases totaling $1,260,462 and 9 sales totaling $593,576. Net insider sentiment: net buying.
Ventyx Biosciences, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Mohan Raju (CEO AND PRESIDENT) — 25 transactions totaling $1,368,005
- Gujrathi Sheila (Not found) — 3 transactions totaling $300,573
- Nuss John (CHIEF SCIENTIFIC OFFICER) — 28 transactions totaling $228,089
- Krueger Christopher W (CHIEF BUSINESS OFFICER) — 3 transactions totaling $8,921
- Auster Martin (CHIEF FINANCIAL OFFICER) — 3 transactions totaling $7,592
View all SEC Filings for Ventyx Biosciences, Inc. (VTYX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Subramaniam Somu | Not found | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.03% |
| March 4, 2026 | Gonzales Roy | Senior VP, Finance | D | Stock Option (Right to Buy) | 70000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.10% |
| March 4, 2026 | Gonzales Roy | Senior VP, Finance | D | Stock Option (Right to Buy) | 37500 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.05% |
| March 4, 2026 | Gonzales Roy | Senior VP, Finance | D | Stock Option (Right to Buy) | 35000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.05% |
| March 4, 2026 | Gonzales Roy | Senior VP, Finance | D | Stock Option (Right to Buy) | 12500 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.02% |
| March 4, 2026 | Gonzales Roy | Senior VP, Finance | D | Stock Option (Right to Buy) | 17500 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.02% |
| March 4, 2026 | Gonzales Roy | Senior VP, Finance | D | Stock Option (Right to Buy) | 109200 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.15% |
| March 4, 2026 | Gonzales Roy | Senior VP, Finance | D | Common Stock | 5313 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.01% |
| March 4, 2026 | Forman Mark S | Chief Medical Officer | D | Stock Option (Right to Buy) | 85000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.12% |
| March 4, 2026 | Forman Mark S | Chief Medical Officer | D | Common Stock | 6000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.01% |
| March 4, 2026 | Mohan Raju | CEO AND PRESIDENT | D | Stock Option (Right to Buy) | 466672 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.65% |
| March 4, 2026 | Mohan Raju | CEO AND PRESIDENT | D | Stock Option (Right to Buy) | 284250 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.40% |
| March 4, 2026 | Mohan Raju | CEO AND PRESIDENT | D | Stock Option (Right to Buy) | 7972 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.01% |
| March 4, 2026 | Mohan Raju | CEO AND PRESIDENT | D | Stock Option (Right to Buy) | 335286 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.47% |
| March 4, 2026 | Mohan Raju | CEO AND PRESIDENT | D | Stock Option (Right to Buy) | 370000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.52% |
| March 4, 2026 | Mohan Raju | CEO AND PRESIDENT | D | Stock Option (Right to Buy) | 473750 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.66% |
| March 4, 2026 | Mohan Raju | CEO AND PRESIDENT | D | Stock Option (Right to Buy) | 155000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.22% |
| March 4, 2026 | Mohan Raju | CEO AND PRESIDENT | D | Stock Option (Right to Buy) | 700000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.98% |
| March 4, 2026 | Mohan Raju | CEO AND PRESIDENT | D | Restricted Stock Units | 23688 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.03% |
| March 4, 2026 | Mohan Raju | CEO AND PRESIDENT | D | Common Stock | 2372863 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 3.33% |
| March 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Stock Option (right to buy) | 108750 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.15% |
| March 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Stock Option (right to buy) | 139722 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.20% |
| March 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Stock Option (right to buy) | 145000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.20% |
| March 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Stock Option (right to buy) | 192778 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.27% |
| March 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Stock Option (right to buy) | 181250 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.25% |
| March 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Stock Option (right to buy) | 125000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.18% |
| March 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Stock Option (right to buy) | 415104 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.58% |
| March 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Restricted Stock Units | 9063 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.01% |
| March 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | D | Common Stock | 489481 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.69% |
| March 4, 2026 | GUJRATHI SHEILA | Not found | D | Stock Option (Right to Buy) | 15937 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.02% |
| March 4, 2026 | GUJRATHI SHEILA | Not found | D | Stock Option (Right to Buy) | 21825 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.03% |
| March 4, 2026 | GUJRATHI SHEILA | Not found | D | Stock Option (Right to Buy) | 277941 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.39% |
| March 4, 2026 | GUJRATHI SHEILA | Not found | D | Stock Option (Right to Buy) | 662369 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.93% |
| March 4, 2026 | GUJRATHI SHEILA | Not found | D | Stock Option (Right to Buy) | 80000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.11% |
| March 4, 2026 | GUJRATHI SHEILA | Not found | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.06% |
| March 4, 2026 | GUJRATHI SHEILA | Not found | D | Stock Option (Right to Buy) | 33000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.05% |
| March 4, 2026 | GUJRATHI SHEILA | Not found | D | Common Stock | 130000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.18% |
| March 4, 2026 | HULME ALLISON | Not found | D | Stock Option (Right to Buy) | 20427 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.03% |
| March 4, 2026 | HULME ALLISON | Not found | D | Stock Option (Right to Buy) | 15937 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.02% |
| March 4, 2026 | HULME ALLISON | Not found | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.03% |
| March 4, 2026 | HULME ALLISON | Not found | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.06% |
| March 4, 2026 | HULME ALLISON | Not found | D | Stock Option (Right to Buy) | 33000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.05% |
| March 4, 2026 | Cadoret-Manier Onaiza | Not found | D | Stock Option (Right to Buy) | 20427 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.03% |
| March 4, 2026 | Cadoret-Manier Onaiza | Not found | D | Stock Option (Right to Buy) | 15937 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.02% |
| March 4, 2026 | Cadoret-Manier Onaiza | Not found | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.03% |
| March 4, 2026 | Cadoret-Manier Onaiza | Not found | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.06% |
| March 4, 2026 | Cadoret-Manier Onaiza | Not found | D | Stock Option (Right to Buy) | 33000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.05% |
| March 4, 2026 | Moore Matthew Richard | Chief Operating Officer | D | Stock Option (Right to Buy) | 320000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.45% |
| March 4, 2026 | Moore Matthew Richard | Chief Operating Officer | D | Stock Option (Right to Buy) | 145000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.20% |
| March 4, 2026 | White William Richard | Not found | D | Stock Option (Right to Buy) | 15937 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.02% |
| March 4, 2026 | White William Richard | Not found | D | Stock Option (Right to Buy) | 21825 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.03% |
| March 4, 2026 | White William Richard | Not found | D | Stock Option (Right to Buy) | 119120 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.17% |
| March 4, 2026 | White William Richard | Not found | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.03% |
| March 4, 2026 | White William Richard | Not found | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.06% |
| March 4, 2026 | White William Richard | Not found | D | Stock Option (Right to Buy) | 33000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.05% |
| March 4, 2026 | Subramaniam Somu | Not found | D | Stock Option (Right to Buy) | 21825 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.03% |
| March 4, 2026 | Subramaniam Somu | Not found | D | Stock Option (Right to Buy) | 15937 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.02% |
| March 4, 2026 | Forman Mark S | Chief Medical Officer | D | Stock Option (Right to Buy) | 350000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.49% |
| March 4, 2026 | Subramaniam Somu | Not found | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.06% |
| March 4, 2026 | Subramaniam Somu | Not found | D | Stock Option (Right to Buy) | 33000 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.05% |
| March 4, 2026 | Subramaniam Somu | Not found | D | Common Stock | 3337495 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 4.68% |
| Feb. 27, 2026 | Subramaniam Somu | Not found | J | Common Stock | 694718 | $0.00 | 3,337,495.0000 | 71,358,638 | 17.23% | 0.97% |
| Dec. 17, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Units | 34930 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.05% |
| Dec. 17, 2025 | Mohan Raju | CEO AND PRESIDENT | M | Common Stock | 116668 | $0.00 | 2,420,208.0000 | 71,358,638 | 5.06% | 0.16% |
| Dec. 17, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 34930 | $0.00 | 502,156.0000 | 71,358,638 | 7.48% | 0.05% |
| Dec. 17, 2025 | Mohan Raju | CEO AND PRESIDENT | M | Restricted Stock Units | 116668 | $0.00 | 0.0000 | 71,358,638 | 100.00% | 0.16% |
| Dec. 18, 2025 | Mohan Raju | CEO AND PRESIDENT | S | Common Stock | 47345 | $7.72 | 2,372,863.0000 | 71,358,638 | 1.96% | 0.07% |
| Dec. 18, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 12675 | $7.72 | 489,481.0000 | 71,358,638 | 2.52% | 0.02% |
| Nov. 17, 2025 | Gonzales Roy | Senior VP, Finance | A | Common Stock | 1767 | $1.03 | 5,313.0000 | 71,358,638 | 49.83% | 0.00% |
| Nov. 17, 2025 | Forman Mark S | Chief Medical Officer | A | Common Stock | 3000 | $1.03 | 6,000.0000 | 71,358,638 | 100.00% | 0.00% |
| June 5, 2025 | Cadoret-Manier Onaiza | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 71,130,054 | 9999.99% | 0.06% |
| June 5, 2025 | HULME ALLISON | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 71,130,054 | 9999.99% | 0.06% |
| June 5, 2025 | Subramaniam Somu | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 71,130,054 | 9999.99% | 0.06% |
| June 5, 2025 | White William Richard | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 71,130,054 | 9999.99% | 0.06% |
| June 5, 2025 | Gujrathi Sheila | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 71,130,054 | 9999.99% | 0.06% |
| May 15, 2025 | Gonzales Roy | Senior VP, Finance | A | Common Stock | 1750 | $1.03 | 3,546.0000 | 71,130,054 | 97.44% | 0.00% |
| May 15, 2025 | Forman Mark S | Chief Medical Officer | A | Common Stock | 3000 | $1.03 | 3,000.0000 | 71,130,054 | 9999.99% | 0.00% |
| April 2, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 1887 | $1.07 | 467,226.0000 | 71,130,054 | 0.40% | 0.00% |
| March 28, 2025 | Mohan Raju | CEO AND PRESIDENT | M | Common Stock | 11844 | $0.00 | 2,303,540.0000 | 71,130,054 | 0.52% | 0.02% |
| March 28, 2025 | Mohan Raju | CEO AND PRESIDENT | M | Restricted Stock Units | 11844 | $0.00 | 23,688.0000 | 71,130,054 | 33.33% | 0.02% |
| March 28, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 4531 | $0.00 | 469,113.0000 | 71,130,054 | 0.98% | 0.01% |
| March 28, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Units | 4531 | $0.00 | 9,063.0000 | 71,130,054 | 33.33% | 0.01% |
| March 28, 2025 | Subramaniam Somu | Not found | J | Common Stock | 1335450 | $0.00 | 4,032,213.0000 | 71,130,054 | 24.88% | 1.88% |
| March 10, 2025 | Subramaniam Somu | Not found | J | Common Stock | 1735306 | $0.00 | 5,367,663.0000 | 71,130,054 | 24.43% | 2.44% |
| Jan. 2, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 245000 | $0.00 | 245,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | A | Stock Option (right to buy) | 170104 | $0.00 | 170,104.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Mohan Raju | CEO AND PRESIDENT | A | Stock Option (Right to Buy) | 700000 | $0.00 | 700,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Moore Matthew Richard | Chief Operating Officer | A | Stock Option (Right to Buy) | 145000 | $0.00 | 145,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Gonzales Roy | Senior VP, Finance | A | Stock Option (Right to Buy) | 109200 | $0.00 | 109,200.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Gonzales Roy | Senior VP, Finance | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Forman Mark S | Chief Medical Officer | A | Stock Option (Right to Buy) | 85000 | $0.00 | 85,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 27, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 21119 | $2.36 | 464,582.0000 | 0 | 4.35% | 0.00% |
| Dec. 23, 2024 | Gujrathi Sheila | Not found | P | Common Stock | 130000 | $2.31 | 130,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 17, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 34930 | $0.00 | 498,862.0000 | 0 | 7.53% | 0.00% |
| Dec. 19, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 13161 | $2.26 | 485,701.0000 | 0 | 2.64% | 0.00% |
| Dec. 17, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Units | 34930 | $0.00 | 34,930.0000 | 0 | 50.00% | 0.00% |
| Dec. 17, 2024 | Mohan Raju | CEO AND PRESIDENT | M | Common Stock | 116668 | $0.00 | 2,291,696.0000 | 0 | 5.36% | 0.00% |
| Dec. 17, 2024 | Mohan Raju | CEO AND PRESIDENT | M | Restricted Stock Units | 116668 | $0.00 | 116,668.0000 | 0 | 50.00% | 0.00% |
| Dec. 10, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 5377 | $0.20 | 270,375.0000 | 0 | 2.03% | 0.00% |
| Dec. 10, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 193557 | $0.20 | 463,932.0000 | 0 | 71.59% | 0.00% |
| Dec. 10, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Stock Option (right to buy) | 5377 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 10, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Stock Option (Right to Buy) | 193557 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 22, 2024 | Mohan Raju | CEO AND PRESIDENT | P | Common Stock | 238248 | $1.83 | 1,913,276.0000 | 0 | 14.22% | 0.00% |
| Nov. 25, 2024 | Mohan Raju | CEO AND PRESIDENT | P | Common Stock | 261752 | $2.01 | 2,175,028.0000 | 0 | 13.68% | 0.00% |
| Aug. 12, 2024 | Forman Mark S | Chief Medical Officer | A | Stock Option (Right to Buy) | 350000 | $0.00 | 350,000.0000 | 0 | 9999.99% | 0.00% |
| June 24, 2024 | NSV Partners III LP | Not found | J | Common Stock | 641327 | $0.00 | 7,102,969.0000 | 0 | 8.28% | 0.00% |
| June 24, 2024 | Subramaniam Somu | Not found | J | Common Stock | 641327 | $0.00 | 7,102,969.0000 | 0 | 8.28% | 0.00% |
| June 10, 2024 | Mohan Raju | CEO AND PRESIDENT | M | Common Stock | 96778 | $0.20 | 1,675,028.0000 | 0 | 6.13% | 0.00% |
| June 10, 2024 | Mohan Raju | CEO AND PRESIDENT | M | Stock Option (Right to Buy) | 96778 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 6, 2024 | White William Richard | Not found | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Cadoret-Manier Onaiza | Not found | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Gujrathi Sheila | Not found | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | HULME ALLISON | Not found | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Subramaniam Somu | Not found | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 0 | 9999.99% | 0.00% |
| May 16, 2024 | Moore Matthew Richard | Chief Operating Officer | A | Stock Option (Right to Buy) | 320000 | $0.00 | 320,000.0000 | 0 | 9999.99% | 0.00% |
| April 12, 2024 | Subramaniam Somu | Not found | J | Common Stock | 695339 | $0.00 | 7,744,296.0000 | 0 | 8.24% | 0.00% |
| April 12, 2024 | NSV Partners III LP | Not found | J | Common Stock | 695339 | $0.00 | 7,744,296.0000 | 0 | 8.24% | 0.00% |
| April 2, 2024 | Krueger Christopher W | CHIEF BUSINESS OFFICER | S | Common Stock | 1651 | $5.40 | 284,999.0000 | 0 | 0.58% | 0.00% |
| April 2, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 1651 | $5.40 | 264,998.0000 | 0 | 0.62% | 0.00% |
| April 2, 2024 | Mohan Raju | CEO AND PRESIDENT | S | Common Stock | 4312 | $5.40 | 1,578,250.0000 | 0 | 0.27% | 0.00% |
| April 2, 2024 | Auster Martin | CHIEF FINANCIAL OFFICER | S | Common Stock | 1405 | $5.40 | 24,303.0000 | 0 | 5.47% | 0.00% |
| March 28, 2024 | Krueger Christopher W | CHIEF BUSINESS OFFICER | M | Common Stock | 4531 | $0.00 | 286,650.0000 | 0 | 1.61% | 0.00% |
| March 28, 2024 | Krueger Christopher W | CHIEF BUSINESS OFFICER | M | Restricted Stock Units | 4531 | $0.00 | 13,594.0000 | 0 | 25.00% | 0.00% |
| March 28, 2024 | Auster Martin | CHIEF FINANCIAL OFFICER | M | Common Stock | 4531 | $0.00 | 25,708.0000 | 0 | 21.40% | 0.00% |
| March 28, 2024 | Auster Martin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 4531 | $0.00 | 13,594.0000 | 0 | 25.00% | 0.00% |
| March 28, 2024 | Mohan Raju | CEO AND PRESIDENT | M | Common Stock | 11843 | $0.00 | 1,582,562.0000 | 0 | 0.75% | 0.00% |
| March 28, 2024 | Mohan Raju | CEO AND PRESIDENT | M | Restricted Stock Units | 11843 | $0.00 | 35,532.0000 | 0 | 25.00% | 0.00% |
| March 28, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 4531 | $0.00 | 266,649.0000 | 0 | 1.73% | 0.00% |
| March 28, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Units | 4531 | $0.00 | 13,594.0000 | 0 | 25.00% | 0.00% |
| Jan. 21, 2024 | White William Richard | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 21, 2024 | Subramaniam Somu | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 21, 2024 | HULME ALLISON | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 21, 2024 | Cadoret-Manier Onaiza | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 21, 2024 | Gujrathi Sheila | Director | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Auster Martin | Chief Financial Officer | A | Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Mohan Raju | CEO and President | A | Stock Option (Right to Buy) | 155000 | $0.00 | 155,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Nuss John | Chief Scientific Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Krueger Christopher W | Chief Business Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |